Denise Scots-Knight - Insider Trading & Ownership

Entity
Individual
Location
C/O Idenix Pharmaceuticals, Inc., 60 Hampshire Street, Cambridge, MA
Summary
The estimated net worth of Denise Scots-Knight is at least $5.14M dollars as of September 16, 2024. Denise Scots-Knight is the Chief Executive Officer, Director of Mereo BioPharma Group plc and owns shares of Mereo BioPharma Group plc (MREO) stock worth about $4.27M. Denise Scots-Knight is the Director of Elanco Animal Health Inc and owns shares of Elanco Animal Health Inc (ELAN) stock worth about $866K.
All Insider Reports
All Insider Reports

Ownership of Denise Scots-Knight

Symbol Company Relationship Holdings Value Past Year Net Change Change % Report Period
MREO Mereo BioPharma Group plc Chief Executive Officer, Director $4.27M -$845K -16.5% Sep 12, 2024
ELAN Elanco Animal Health Inc Director $866K Nov 30, 2023

Insider Transactions Reported by Denise Scots-Knight:

Sym Company Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.